ISSUE FOCUS FEED & ADDITIVE MAGAZINE January 2023 39 ing ingested in the feed (i.e. mycotoxicosis) or damage the intestine directly (i.e. alpha or NetB toxins produced by Clostridium perfringens). In many cases the damage caused is due to these toxins. Toxins can enter the intestine through the feed or water, or they can be exotoxins or endotoxins produced by resident bacteria. Overall, these toxins can be called biotoxins. If there is interaction of a toxin or toxins with an endothelial cell, reduced nutrient absorption function or death of the cell and subsequent loss of intestinal integrity may be the result. Therefore, a feed additive based on controlling biotoxins but with added benefits to the intestine might help sustain poultry and livestock production even as producers are working to limit antibiotics that have had beneficial results since first introduced to animal agriculture in the 1940’s. Several controlled trials have successfully shown that a commercial product based on controlling biotoxins can have equivalent performance to antibiotics with or without a planned bacterial challenge. Because of this a poultry producer in southern Brazil conducted is large-scale study to determine the benefits of this product at the commercial level. The study used approximately 180,000 broilers from three farms. Each farm fed one house a control diet with their standard feed, which contained a mycotoxin binder and enramycin. A second house on each farm was fed a diet where the antibiotic and the mycotoxin binder were removed, and a feed additive was included. The feed additive was developed to control biotoxins, both fungal and bacterial, but also to provide energy to the epithelial cells lining the gastro-intestinal tract and prepare the immune system for future challenges. The chicks that were supplied to the farms for evaluation were from breeders of the same age. Every week a sample of approximately 1% of the birds were weighed in each barn and the mortalities in each barn were tabulated. Birds were harvested at 47.29 days DRIVE PROFITS NATURALLY Amlan International, the creator of proven intestinal health feed additives like Varium® and Calibrin®-Z, recently launched Phylox® — an innovative alternative to anticoccidial drugs and vaccines that helps improve production economics. WITH SUPERIOR MINERAL TECHNOLOGY REQUEST A TRIAL TODAY AT AMLAN.COM ® ™ Product availability may vary by country, associated claims do not constitute medical claims and may differ based on government requirements.
RkJQdWJsaXNoZXIy MTUxNjkxNQ==